Stem Cell Therapy

1. What is Stem Cell Therapy?

Stem cell therapy involves using stem cells or stem-cell-derived products to replace, repair, or influence damaged tissues or abnormal immune responses. The type of cells and treatment protocol depend on the disease being treated.

2. What conditions can be treated with Stem Cells?

Established stem-cell treatments include hematopoietic stem-cell transplantation for certain blood cancers and blood or immune disorders. Other applications involving neurological, orthopedic, autoimmune, cardiac, and degenerative conditions remain under varying levels of clinical research and should not be presented as universally established treatments.

3. What types of stem cells are used?

Depending on the treatment, cells may come from bone marrow, peripheral blood, umbilical cord blood, adipose tissue, or other sources. Hematopoietic stem cells and mesenchymal stromal/stem cells have different biological properties and clinical applications.

4. How is Stem Cell Therapy administered?

Administration depends on the condition and protocol. Cells may be delivered through intravenous infusion, direct injection into a specific tissue or joint, or transplantation following conditioning therapy in hematopoietic stem-cell transplantation.

5. Is Stem Cell Therapy approved for every condition?

No. This is an important distinction. Some stem-cell treatments are established medical therapies, while many commercially promoted regenerative treatments remain investigational or have limited evidence. Treatment should therefore be considered only after specialist assessment of the specific indication and protocol.

6. How is a patient evaluated before treatment?

Evaluation may include medical history, physical examination, imaging, blood tests, disease-specific investigations, and sometimes genetic, molecular, or tissue testing. The specialist also determines whether the proposed stem-cell approach is medically appropriate and supported by adequate evidence.

7. What are the potential benefits?

For established indications, stem-cell transplantation can replace diseased or damaged blood-forming systems and can be potentially curative for certain serious disorders. For investigational regenerative applications, the potential benefits depend on the disease and are still being evaluated through clinical research.

8. What are the risks?

Risks vary significantly according to the cell type and treatment method. They may include infection, bleeding, immune reactions, blood clots, treatment-related organ complications, unwanted tissue effects, and complications associated with the procedure used to administer the cells. In transplantation, complications can be considerably more serious.

9. Why consider Stem Cell Therapy in India?

India has established hematopoietic stem-cell transplant programs, specialist centres, advanced cell-processing facilities, and comparatively affordable treatment costs. For investigational regenerative therapies, patients should specifically verify the clinical evidence, regulatory status, treating institution, and whether the treatment is being offered within an appropriately governed clinical protocol.

10. How can Medavelle help?

Medavelle can facilitate preliminary review of medical records and investigations, connect patients with an appropriate specialist, determine whether an established or investigational stem-cell approach is relevant, coordinate treatment at a suitable centre, obtain an individualized cost estimate, and assist with travel, accommodation, and hospital coordination in India.